Rudolph M. Egeler

Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Clinicogenomic associations in childhood Langerhans cell histiocytosis: an international cohort study.

Clinicogenomic associations in childhood Langerhans cell histiocytosis: an international cohort study.

Journal: Blood advances

Published: April 26, 2022

The international dataset on the association between Langerhans Cell Histiocytosis and other malignancies.

The international dataset on the association between Langerhans Cell Histiocytosis and other malignancies.

Journal: Data in brief

Published: April 19, 2022

Langerhans cell histiocytosis and associated malignancies: A retrospective analysis of 270 patients.

Langerhans cell histiocytosis and associated malignancies: A retrospective analysis of 270 patients.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 21, 2021

The coming of age of Langerhans cell histiocytosis.

The coming of age of Langerhans cell histiocytosis.

Journal: Nature immunology

Published: December 14, 2019

Apparent Lack of BRAFV600E Derived HLA Class I Presented Neoantigens Hampers Neoplastic Cell Targeting by CD8+ T Cells in Langerhans Cell Histiocytosis.

Apparent Lack of BRAFV600E Derived HLA Class I Presented Neoantigens Hampers Neoplastic Cell Targeting by CD8+ T Cells in Langerhans Cell Histiocytosis.

Journal: Frontiers in immunology

Published: October 23, 2019

Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study.

Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study.

Journal: Blood

Published: June 04, 2017

Successful Therapy Reduction and Intensification for Childhood Acute Lymphoblastic Leukemia Based on Minimal Residual Disease Monitoring: Study ALL10 From the Dutch Childhood Oncology Group.

Successful Therapy Reduction and Intensification for Childhood Acute Lymphoblastic Leukemia Based on Minimal Residual Disease Monitoring: Study ALL10 From the Dutch Childhood Oncology Group.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: June 09, 2016

Enhanced human hematopoietic stem and progenitor cell engraftment by blocking donor T cell-mediated TNFα signaling.

Enhanced human hematopoietic stem and progenitor cell engraftment by blocking donor T cell-mediated TNFα signaling.

Journal: Science translational medicine

Published: June 09, 2016

Bisphosphonates in Langerhans Cell Histiocytosis: An International Retrospective Case Series.

Bisphosphonates in Langerhans Cell Histiocytosis: An International Retrospective Case Series.

Journal: Mediterranean journal of hematology and infectious diseases

Published: June 01, 2016

Overexpression of LMO2 causes aberrant human T-Cell development in vivo by three potentially distinct cellular mechanisms.

Overexpression of LMO2 causes aberrant human T-Cell development in vivo by three potentially distinct cellular mechanisms.

Journal: Experimental hematology

Published: May 26, 2016

Langerhans cell histiocytosis is a neoplasm and consequently its recurrence is a relapse: In memory of Bob Arceci.

Langerhans cell histiocytosis is a neoplasm and consequently its recurrence is a relapse: In memory of Bob Arceci.

Journal: Pediatric blood & cancer

Published: March 30, 2016

Erratum to: Intact IFN-γR1 Expression and Function Distinguishes Langerhans Cell Histiocytosis From Mendelian Susceptibility to Mycobacterial Disease.

Erratum to: Intact IFN-γR1 Expression and Function Distinguishes Langerhans Cell Histiocytosis From Mendelian Susceptibility to Mycobacterial Disease.

Journal: Journal of clinical immunology

Published: January 20, 2016

Showing 1-12 of 47

Last Updated: 09/26/2026